TITLE

67-Year-Old Man With Hepatitis C Infection and Abdominal Distention

AUTHOR(S)
Choong, Nichols W.W.; Ashfandiyar, Sohail; Roberts, Lewis R.
PUB. DATE
February 2003
SOURCE
Mayo Clinic Proceedings;Feb2003, Vol. 78 Issue 2, p217
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents the case of an aged man of history of chronic hepatitis C infection and abdominal distention. Results of initial examination and laboratory tests; Incidence of hepatocellular carcinoma (HCC); Factors for consideration when selecting treatment strategy for patients with HCC.
ACCESSION #
9749245

 

Related Articles

  • US reports increase in liver cancer. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);03/20/99, Vol. 318 Issue 7186, p755 

    Reports on the increase incidence of hepatocellular carcinoma in the United States. Percentage increase from 1976 to 1995; Main risk factors associated with hepatocellular carcinoma; Belief of many older Americans with hepatitis C on how the disease is contracted.

  • Type C chronic hepatitis with the discovery of a small hepatocellular carcinoma 7 years after successful interferon therapy. Tomimatsu, Masahiko; Endo, Hitoshi; Kitazawa, Misa; Iga, Daijiro; Fujimoto, Tomoko; Ohkawa, Shin-Ichiro; Kajiyama, Hideki; Katagiri, Satoshi; Harada, Nobuhiko; Yamamoto, Masakazu; Takasaki, Ken // Journal of Gastroenterology;2003, Vol. 38 Issue 4, p395 

    The patient, a 61-year-old man, had sustained injuries in a traffic accident at the age of 26, for which he received a blood transfusion. Since 1988 (age, 49 years), abnormal hepatic function had been detected, and, because of the presence of hepatitis C virus antibodies, he was diagnosed as...

  • HCV protein causes cancer.  // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p943 

    Discusses findings of Japanese researchers that the hepatitis C virus (HVC) core protein induces hepatocellular carcinoma. Development of hepatic steatosis in laboratory mice as histologic feature of chronic hepatitis C; Characteristics of mice carrying HCV envelope genes.

  • Incomplete response of interferon treatment has an important role for the prevention of hepatocellular carcinoma. Hayashi, Norio // Journal of Gastroenterology;1999, Vol. 34 Issue 5, p655 

    Editorial. Focuses on the incidence of hepatocellular carcinoma (HCC) in Japan. Incidence rate of HCC in cirrhotic patients with antibodies to hepatitis C virus (HCV); Treatment of HCV.

  • Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C. Fujita, Naoki; Takei, Yoshiyuki // Journal of Gastroenterology;Nov2007, Vol. 42 Issue 11, p923 

    The article discusses various reports publishes within the issue, including one on chronic hepatitis C virus and another on iron reduction.

  • An Unusual Presentation of Hepatocellular Carcinoma. Fitzmorris, Paul Stephen; Morris, Jason L; Fettig, David Michael // American Journal of Gastroenterology;Oct2015, Vol. 110 Issue 10, p1395 

    A case study of 59-year-old man with a history of hepatitis C and alcoholic cirrhosisis presented, and mentions that upon fine-needle aspiration of the mass revealed hepatocellular carcinoma.

  • Accumulation of 8-n itroguanine in the liver of chronic hepatitis C patients without sustained virological response after completion of interferon therapy. Kaito, Masahiko; Horiike, Shinichiro; Tanaka, Hideaki; Fujita, Naoki; Adachi, Yukihiko // Journal of Gastroenterology;Jul2006, Vol. 41 Issue 7, p713 

    The article describes the use of 8-nitroguanine as a biomarker for evaluating the severity of hepatitis C virus-induced chronic inflammation in relation to hepatocellular carcinoma. Interferon therapy was found to decrease the accumulation of 8-nitroguanine in the liver. This suggests that...

  • The role of hepatitis C virus in the pathogenesis of hepatocellular carcinoma. Tran, Gui // Bioscience Horizons: The National Undergraduate Research Journal;Jun2008, Vol. 1 Issue 2, p167 

    Hepatitis C virus (HCV) is a worldwide pandemic, chronically affecting over 170 million people worldwide. It is a major risk factor for the development of hepatocellular carcinoma (HCC) and there is increasing experimental evidence to suggest that the virus plays a direct role in neoplastic...

  • Discovery of Small-Molecule Inhibitors of HCV NS3-4A Protease as Potential Therapeutic Agents against HCV Infection. Shu-Hui Chen; Seng-Lai Tan // Current Medicinal Chemistry;2005, Vol. 12 Issue 20, p2317 

    Chronic infection with hepatitis C virus (HCV) is associated with liver cirrhosis that often leads to hepatic failure and hepatocellular carcinoma (HCC). HCV infection has become a global health threat and the main cause of adult liver transplants in developed nations. Current approved anti-HCV...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics